Four goals PhRMA: CEO Action Plan for Diversity and Inclusion Pledge

04 March 2020

GMP News

As part of the biopharmaceutical industry’s commitment to advance diversity and inclusion in the workplace, president and chief executive officer Stephen J. Ubl of the Pharmaceutical Research and Manufacturers of America (PhRMA) signed the CEO Action for Diversity & Inclusion Pledge. PhRMA joins over 900 businesses who have committed to this pledge.

“PhRMA has a unique ability to highlight our members’ diversity and inclusion efforts and to help our industry learn from each other on how to build stronger, more diverse workforces,” said Ubl. “This pledge shows our commitment to diversity and inclusion – both internally and in the biopharmaceutical industry – which are essential to unlocking the scientific challenges that lead to new medicines and to helping the patients we serve.”

The CEO Action Plan for Diversity & Inclusion Pledge includes four goals that PhRMA is committed to working toward:

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more